After a minute of basic DD…I can tell you that he provided capital market & accounting advisory services while working for an accounting firm that generated 45.1B in revenues in 2021 and has 295,000 employees in 157 countries.
Was also able to find the med tech group mentioned, they are listed on the NYSE. With 99% certainty - you would recognize this giant, well established company.
On 12/18/21, VITX won yet another “Product of the year” award by a group bigger than just Sammer’s mom, although she’s probably exceptionally proud that her son as developed these unique products & is selling/marketing them on them on a global level.
I for one am glad they aren’t wasting money on an office lease. Those funds are better spent on sales, marketing, inventory & product development.
VITX management just cancelled all their protected Pref B shares to common shares at a rate of $.103 per share. It would make ZERO sense for them to R/S their own newly issued, RESTRICTED, common shares. Not happening.
“September before they can show any sales”??? Please show us where the company has said this? I’m expecting their 2022 Q2 numbers to be released in filings on March 15th. Should see a bit of growth, but the bigger sales revenues will begin after the official US launch in May. Not to mention the other counties they are expanding into: Brazil, Africa, Caribbean, Russia…etc.
Go $VITX. 2022 will be HUGE.
News 
Market Data 
Discover 
